235 related articles for article (PubMed ID: 21116692)
21. Development of a new formulation of roflumilast for pulmonary drug delivery to treat inflammatory lung conditions.
Suzuki ÉY; Amaro MI; de Almeida GS; Cabral LM; Healy AM; de Sousa VP
Int J Pharm; 2018 Oct; 550(1-2):89-99. PubMed ID: 30130605
[TBL] [Abstract][Full Text] [Related]
22. Optimization and characterization of dry powder of fanhuncaoin for inhalation based on selection of excipients.
Yang XB; Wang XB; Pan WS; Xi RG; Wang YN; Liu D; Shi Y; Jiang S
Chem Pharm Bull (Tokyo); 2011; 59(8):929-37. PubMed ID: 21804235
[TBL] [Abstract][Full Text] [Related]
23. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
Li X; Vogt FG; Hayes D; Mansour HM
Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
[TBL] [Abstract][Full Text] [Related]
24. Critical attributes of fine excipient materials in carrier-based dry powder inhalation formulations: The particle shape and surface properties.
Elsayed MMA; Alfagih IM; Brockbank K; Aodah AH; Ali R; Almansour K; Shalash AO
Int J Pharm; 2024 Apr; 655():123966. PubMed ID: 38452834
[TBL] [Abstract][Full Text] [Related]
25. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery.
Wu X; Zhang W; Hayes D; Mansour HM
Int J Nanomedicine; 2013; 8():1269-83. PubMed ID: 23569375
[TBL] [Abstract][Full Text] [Related]
26. Powder, capsule and device: An imperative ménage à trois for respirable dry powders.
Schoubben A; Blasi P; Giontella A; Giovagnoli S; Ricci M
Int J Pharm; 2015 Oct; 494(1):40-8. PubMed ID: 26255220
[TBL] [Abstract][Full Text] [Related]
27. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
[TBL] [Abstract][Full Text] [Related]
28. Formulation and characterization of lipid-coated tobramycin particles for dry powder inhalation.
Pilcer G; Sebti T; Amighi K
Pharm Res; 2006 May; 23(5):931-40. PubMed ID: 16715383
[TBL] [Abstract][Full Text] [Related]
29. Study on the Pulmonary Delivery System of Apigenin-Loaded Albumin Nanocarriers with Antioxidant Activity.
Pápay ZE; Kósa A; Böddi B; Merchant Z; Saleem IY; Zariwala MG; Klebovich I; Somavarapu S; Antal I
J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):274-288. PubMed ID: 28282259
[TBL] [Abstract][Full Text] [Related]
30. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterisation of novel spray-dried nano-structured para-aminosalicylic acid particulates for pulmonary delivery: impact of ammonium carbonate on morphology, chemical composition and solid state.
Gad S; Tajber L; Corrigan OI; Healy AM
J Pharm Pharmacol; 2012 Sep; 64(9):1264-74. PubMed ID: 22881439
[TBL] [Abstract][Full Text] [Related]
32. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
You Y; Zhao M; Liu G; Tang X
J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
[TBL] [Abstract][Full Text] [Related]
33. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
[TBL] [Abstract][Full Text] [Related]
34. Low powder mass filling of dry powder inhalation formulations.
Eskandar F; Lejeune M; Edge S
Drug Dev Ind Pharm; 2011 Jan; 37(1):24-32. PubMed ID: 20738180
[TBL] [Abstract][Full Text] [Related]
35. Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infection.
Arora S; Haghi M; Loo CY; Traini D; Young PM; Jain S
Mol Pharm; 2015 Jun; 12(6):2001-9. PubMed ID: 25923171
[TBL] [Abstract][Full Text] [Related]
36. Spray drying lactose from organic solvent suspensions for aerosol delivery to the lungs.
Ke WR; Chang RYK; Kwok PCL; Chen D; Chan HK
Int J Pharm; 2020 Dec; 591():119984. PubMed ID: 33069893
[TBL] [Abstract][Full Text] [Related]
37. Characterisation and deposition studies of recrystallised lactose from binary mixtures of ethanol/butanol for improved drug delivery from dry powder inhalers.
Kaialy W; Martin GP; Ticehurst MD; Royall P; Mohammad MA; Murphy J; Nokhodchi A
AAPS J; 2011 Mar; 13(1):30-43. PubMed ID: 21057906
[TBL] [Abstract][Full Text] [Related]
38. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
Shalash AO; Molokhia AM; Elsayed MM
Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
[TBL] [Abstract][Full Text] [Related]
39. The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules.
Sou T; Kaminskas LM; Nguyen TH; Carlberg R; McIntosh MP; Morton DA
Eur J Pharm Biopharm; 2013 Feb; 83(2):234-43. PubMed ID: 23183447
[TBL] [Abstract][Full Text] [Related]
40. The use of sodium carboxymethylcellulose in the preparation of spray-dried proteins for pulmonary drug delivery.
Li HY; Song X; Seville PC
Eur J Pharm Sci; 2010 Apr; 40(1):56-61. PubMed ID: 20188824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
